

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.26468366 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.92039981 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.92039981 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.74282270 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.74282270 |
| 6 | primary alcohol catabolic process (GO:0034310) | 6.25699052 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.10341008 |
| 8 | * cysteine metabolic process (GO:0006534) | 5.86314489 |
| 9 | glycoside metabolic process (GO:0016137) | 5.50504591 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.42933119 |
| 11 | retinal metabolic process (GO:0042574) | 5.39439214 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.33581545 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 5.33581545 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 5.33581545 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.22632249 |
| 16 | lysine catabolic process (GO:0006554) | 5.13487723 |
| 17 | lysine metabolic process (GO:0006553) | 5.13487723 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.12502958 |
| 19 | kynurenine metabolic process (GO:0070189) | 5.03562098 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.01737909 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 4.96609800 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 4.70184672 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.54995326 |
| 24 | aldehyde catabolic process (GO:0046185) | 4.46545712 |
| 25 | aromatic amino acid family metabolic process (GO:0009072) | 4.45066070 |
| 26 | diterpenoid biosynthetic process (GO:0016102) | 4.42163743 |
| 27 | drug transmembrane transport (GO:0006855) | 4.41578104 |
| 28 | bile acid metabolic process (GO:0008206) | 4.39616115 |
| 29 | urea cycle (GO:0000050) | 4.39152377 |
| 30 | urea metabolic process (GO:0019627) | 4.39152377 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.38299464 |
| 32 | complement activation, alternative pathway (GO:0006957) | 4.33215689 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.30596572 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.29286440 |
| 35 | protein carboxylation (GO:0018214) | 4.29286440 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.22616186 |
| 37 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.22272261 |
| 38 | high-density lipoprotein particle remodeling (GO:0034375) | 4.21873773 |
| 39 | negative regulation of fibrinolysis (GO:0051918) | 4.20883434 |
| 40 | progesterone metabolic process (GO:0042448) | 4.19876358 |
| 41 | * serine family amino acid metabolic process (GO:0009069) | 4.17797186 |
| 42 | cofactor catabolic process (GO:0051187) | 4.17164989 |
| 43 | ethanol oxidation (GO:0006069) | 4.15978952 |
| 44 | heme transport (GO:0015886) | 4.15591481 |
| 45 | nitrogen cycle metabolic process (GO:0071941) | 4.14361010 |
| 46 | serine family amino acid biosynthetic process (GO:0009070) | 4.12623735 |
| 47 | urate metabolic process (GO:0046415) | 4.12201735 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.09906160 |
| 49 | quinone metabolic process (GO:1901661) | 4.09852018 |
| 50 | regulation of protein activation cascade (GO:2000257) | 4.09333048 |
| 51 | iron ion import (GO:0097286) | 4.06019371 |
| 52 | short-chain fatty acid metabolic process (GO:0046459) | 4.05275098 |
| 53 | cellular glucuronidation (GO:0052695) | 4.03794504 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.02047745 |
| 55 | regulation of fibrinolysis (GO:0051917) | 3.98390396 |
| 56 | plasma lipoprotein particle clearance (GO:0034381) | 3.95720028 |
| 57 | * glutamate metabolic process (GO:0006536) | 3.94922738 |
| 58 | tyrosine metabolic process (GO:0006570) | 3.94852970 |
| 59 | coenzyme catabolic process (GO:0009109) | 3.89610422 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 3.89594551 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 3.89566273 |
| 62 | macromolecular complex remodeling (GO:0034367) | 3.89566273 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.89566273 |
| 64 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.87886680 |
| 65 | regulation of triglyceride catabolic process (GO:0010896) | 3.86783300 |
| 66 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.83641386 |
| 67 | regulation of complement activation (GO:0030449) | 3.83071358 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 3.81426714 |
| 69 | uronic acid metabolic process (GO:0006063) | 3.80723431 |
| 70 | glucuronate metabolic process (GO:0019585) | 3.80723431 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 3.79795457 |
| 72 | amine catabolic process (GO:0009310) | 3.79795457 |
| 73 | glycine metabolic process (GO:0006544) | 3.79406503 |
| 74 | cell adhesion mediated by integrin (GO:0033627) | 3.78962676 |
| 75 | triglyceride homeostasis (GO:0070328) | 3.78449651 |
| 76 | acylglycerol homeostasis (GO:0055090) | 3.78449651 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 3.74811620 |
| 78 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.74129963 |
| 79 | reverse cholesterol transport (GO:0043691) | 3.73190212 |
| 80 | bile acid and bile salt transport (GO:0015721) | 3.72359427 |
| 81 | drug transport (GO:0015893) | 3.72123643 |
| 82 | aspartate family amino acid catabolic process (GO:0009068) | 3.68997425 |
| 83 | acetyl-CoA metabolic process (GO:0006084) | 3.68693682 |
| 84 | intestinal cholesterol absorption (GO:0030299) | 3.64219873 |
| 85 | benzene-containing compound metabolic process (GO:0042537) | 3.63539456 |
| 86 | drug catabolic process (GO:0042737) | 3.61599151 |
| 87 | regulation of cholesterol esterification (GO:0010872) | 3.61158139 |
| 88 | plasma lipoprotein particle assembly (GO:0034377) | 3.57732608 |
| 89 | terpenoid biosynthetic process (GO:0016114) | 3.57578092 |
| 90 | negative regulation of cholesterol transport (GO:0032375) | 3.55227557 |
| 91 | negative regulation of sterol transport (GO:0032372) | 3.55227557 |
| 92 | imidazole-containing compound metabolic process (GO:0052803) | 3.52024530 |
| 93 | cholesterol efflux (GO:0033344) | 3.50636907 |
| 94 | * response to nitrosative stress (GO:0051409) | 3.49898509 |
| 95 | fatty acid oxidation (GO:0019395) | 3.49764537 |
| 96 | organic acid catabolic process (GO:0016054) | 3.48815086 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.48815086 |
| 98 | heme metabolic process (GO:0042168) | 3.45791494 |
| 99 | carnitine metabolic process (GO:0009437) | 3.44337382 |
| 100 | lipid oxidation (GO:0034440) | 3.44130239 |
| 101 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.44016659 |
| 102 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.44016659 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.43369819 |
| 104 | ketone body metabolic process (GO:1902224) | 3.42968844 |
| 105 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.42672265 |
| 106 | fatty acid beta-oxidation (GO:0006635) | 3.42514711 |
| 107 | response to mercury ion (GO:0046689) | 3.40876387 |
| 108 | valine metabolic process (GO:0006573) | 3.40048894 |
| 109 | phospholipid efflux (GO:0033700) | 3.39215274 |
| 110 | flavonoid metabolic process (GO:0009812) | 3.35793494 |
| 111 | fibrinolysis (GO:0042730) | 3.35612126 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.33959355 |
| 113 | sterol homeostasis (GO:0055092) | 3.32255691 |
| 114 | response to arsenic-containing substance (GO:0046685) | 3.27680022 |
| 115 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.15981492 |
| 116 | primary alcohol metabolic process (GO:0034308) | 3.14563737 |
| 117 | cellular aldehyde metabolic process (GO:0006081) | 3.14348405 |
| 118 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.07957213 |
| 119 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.03699847 |
| 120 | retinoic acid metabolic process (GO:0042573) | 3.03517561 |
| 121 | macroautophagy (GO:0016236) | 3.00100190 |
| 122 | cyclooxygenase pathway (GO:0019371) | 2.94249678 |
| 123 | regulation of metalloenzyme activity (GO:0048552) | 2.93157251 |
| 124 | C21-steroid hormone metabolic process (GO:0008207) | 2.92089429 |
| 125 | xenobiotic catabolic process (GO:0042178) | 2.85590339 |
| 126 | retinol metabolic process (GO:0042572) | 2.81064235 |
| 127 | porphyrin-containing compound metabolic process (GO:0006778) | 2.74974879 |
| 128 | regulation of vitamin metabolic process (GO:0030656) | 2.72611553 |
| 129 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.70294932 |
| 130 | cellular ketone metabolic process (GO:0042180) | 2.66484091 |
| 131 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.66278476 |
| 132 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.65760168 |
| 133 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.64522399 |
| 134 | ER overload response (GO:0006983) | 2.59998168 |
| 135 | hepatocyte differentiation (GO:0070365) | 2.59618720 |
| 136 | phenylpropanoid metabolic process (GO:0009698) | 2.58720155 |
| 137 | positive regulation of glycolytic process (GO:0045821) | 2.58366353 |
| 138 | cellular response to vitamin D (GO:0071305) | 2.56158076 |
| 139 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.53924832 |
| 140 | L-ascorbic acid metabolic process (GO:0019852) | 2.53487959 |
| 141 | sphingoid metabolic process (GO:0046519) | 2.49668848 |
| 142 | COPII vesicle coating (GO:0048208) | 2.49204567 |
| 143 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.46517883 |
| 144 | regulation of early endosome to late endosome transport (GO:2000641) | 2.46317560 |
| 145 | cellular response to arsenic-containing substance (GO:0071243) | 2.46170261 |
| 146 | tetrahydrofolate metabolic process (GO:0046653) | 2.46066308 |
| 147 | exogenous drug catabolic process (GO:0042738) | 2.46009519 |
| 148 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.45098050 |
| 149 | hemoglobin metabolic process (GO:0020027) | 2.41163962 |
| 150 | intestinal absorption (GO:0050892) | 2.40869758 |
| 151 | axonemal dynein complex assembly (GO:0070286) | 2.40820521 |
| 152 | regulation of translational termination (GO:0006449) | 2.38939233 |
| 153 | androgen biosynthetic process (GO:0006702) | 2.38920353 |
| 154 | erythrocyte maturation (GO:0043249) | 2.38352818 |
| 155 | regulation of response to tumor cell (GO:0002834) | 2.38100088 |
| 156 | positive regulation of response to tumor cell (GO:0002836) | 2.38100088 |
| 157 | positive regulation of immune response to tumor cell (GO:0002839) | 2.38100088 |
| 158 | regulation of immune response to tumor cell (GO:0002837) | 2.38100088 |
| 159 | tetrapyrrole biosynthetic process (GO:0033014) | 2.37632197 |
| 160 | desmosome organization (GO:0002934) | 2.36256471 |
| 161 | positive regulation of protein autophosphorylation (GO:0031954) | 2.34761456 |
| 162 | sphingosine metabolic process (GO:0006670) | 2.34241269 |
| 163 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.33226955 |
| 164 | negative regulation of hormone metabolic process (GO:0032351) | 2.32897759 |
| 165 | secondary metabolic process (GO:0019748) | 2.32575944 |
| 166 | magnesium ion transport (GO:0015693) | 2.31719316 |
| 167 | lung vasculature development (GO:0060426) | 2.29229185 |
| 168 | mesodermal cell differentiation (GO:0048333) | 2.28967708 |
| 169 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.28873805 |
| 170 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.26454480 |
| 171 | hemidesmosome assembly (GO:0031581) | 2.25861346 |
| 172 | ethanol metabolic process (GO:0006067) | 2.21663442 |
| 173 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.20284332 |
| 174 | renal absorption (GO:0070293) | 2.17459645 |
| 175 | polyketide metabolic process (GO:0030638) | 10.5407828 |
| 176 | doxorubicin metabolic process (GO:0044598) | 10.5407828 |
| 177 | daunorubicin metabolic process (GO:0044597) | 10.5407828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.32897987 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.28140669 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.04325594 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.62284696 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.99135894 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.55737475 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.36208553 |
| 8 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.96461335 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.77879669 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.04669586 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.67251300 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39780028 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.29202031 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.17084202 |
| 15 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.16644140 |
| 16 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.16644140 |
| 17 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5727944 |
| 18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.96790897 |
| 19 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.90411774 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.85669226 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75514327 |
| 22 | CJUN_26792858_Chip-Seq_BT549_Human | 1.71813782 |
| 23 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.70352233 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.69203578 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61842561 |
| 26 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.60196570 |
| 27 | GATA1_19941826_ChIP-Seq_K562_Human | 1.54989853 |
| 28 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50438147 |
| 29 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.48446187 |
| 30 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.47799033 |
| 31 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.47717775 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47387957 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.47122431 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42791272 |
| 35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.41933866 |
| 36 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.41079692 |
| 37 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.40510406 |
| 38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39486116 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37514132 |
| 40 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.36769474 |
| 41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36641814 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35322577 |
| 43 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35254300 |
| 44 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.35126572 |
| 45 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.31809954 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.27741250 |
| 47 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27059020 |
| 48 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.26575302 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25469395 |
| 50 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.23926732 |
| 51 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22872571 |
| 52 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21138796 |
| 53 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.20719264 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.20147374 |
| 55 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19258906 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.19258664 |
| 57 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19187210 |
| 58 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.18843283 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.18352129 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.17644389 |
| 61 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16333762 |
| 62 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.16119125 |
| 63 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.15977127 |
| 64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14658135 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12174324 |
| 66 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.11036357 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08528187 |
| 68 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08228653 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07680907 |
| 70 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.07450759 |
| 71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06822290 |
| 72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.06670152 |
| 73 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06387225 |
| 74 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06364190 |
| 75 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05876737 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03753984 |
| 77 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03284690 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.03106663 |
| 79 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.02346400 |
| 80 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.01309389 |
| 81 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.00798174 |
| 82 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00056976 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99735579 |
| 84 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99479294 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.99469987 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.99428116 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99220769 |
| 88 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.98688028 |
| 89 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97049553 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.96337792 |
| 91 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95276957 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.92784939 |
| 93 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91284860 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90838328 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90324089 |
| 96 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.89876563 |
| 97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89649718 |
| 98 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88578301 |
| 99 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87662417 |
| 100 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.87170454 |
| 101 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.86875463 |
| 102 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.86527805 |
| 103 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86344773 |
| 104 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86010881 |
| 105 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86010881 |
| 106 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85105003 |
| 107 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.84796378 |
| 108 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.82633941 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81965569 |
| 110 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.81539767 |
| 111 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.81134455 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81050754 |
| 113 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80838553 |
| 114 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78910481 |
| 115 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77560599 |
| 116 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.77092154 |
| 117 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.76519959 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76235735 |
| 119 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.75565877 |
| 120 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74824087 |
| 121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73472578 |
| 122 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.72761051 |
| 123 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.72002757 |
| 124 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71840165 |
| 125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71391874 |
| 126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.69085170 |
| 127 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.68963842 |
| 128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.68225351 |
| 129 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.67880544 |
| 130 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67021559 |
| 131 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.65502168 |
| 132 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64724859 |
| 133 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.62609176 |
| 134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60748565 |
| 135 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.60456159 |
| 136 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.60222752 |
| 137 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59293497 |
| 138 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.58482371 |
| 139 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.56994595 |
| 140 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56639214 |
| 141 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.56148832 |
| 142 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55944583 |
| 143 | AR_20517297_ChIP-Seq_VCAP_Human | 0.54184137 |
| 144 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.54120770 |
| 145 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.54081934 |
| 146 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.52762772 |
| 147 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.52489983 |
| 148 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.51962116 |
| 149 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51873825 |
| 150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.50688224 |
| 151 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.50639595 |
| 152 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.50048489 |
| 153 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.49637680 |
| 154 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.48495532 |
| 155 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.48407764 |
| 156 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.48359294 |
| 157 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48329635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.50814039 |
| 2 | MP0005360_urolithiasis | 6.93768441 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.29011071 |
| 4 | MP0005365_abnormal_bile_salt | 5.15129714 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.74976432 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.56250410 |
| 7 | MP0003195_calcinosis | 3.67355048 |
| 8 | MP0003950_abnormal_plasma_membrane | 3.64837603 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 3.32715374 |
| 10 | MP0003252_abnormal_bile_duct | 3.27117079 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 3.12392041 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 3.08323850 |
| 13 | MP0005083_abnormal_biliary_tract | 2.97108513 |
| 14 | * MP0005332_abnormal_amino_acid | 2.90344570 |
| 15 | MP0002877_abnormal_melanocyte_morpholog | 2.88484894 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.82393997 |
| 17 | MP0009840_abnormal_foam_cell | 2.77004596 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 2.66016033 |
| 19 | MP0006054_spinal_hemorrhage | 2.52425379 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.39486884 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.25441230 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.23824535 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.17332958 |
| 24 | MP0004147_increased_porphyrin_level | 2.12351388 |
| 25 | * MP0003186_abnormal_redox_activity | 2.07694897 |
| 26 | MP0000609_abnormal_liver_physiology | 1.96723929 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 1.95342237 |
| 28 | MP0003566_abnormal_cell_adhesion | 1.78781222 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.77279050 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.74288159 |
| 31 | * MP0005319_abnormal_enzyme/_coenzyme | 1.74116760 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.71403965 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.68583779 |
| 34 | MP0003868_abnormal_feces_composition | 1.67846622 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.65133052 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.63192773 |
| 37 | MP0004043_abnormal_pH_regulation | 1.61345905 |
| 38 | MP0003724_increased_susceptibility_to | 1.54877933 |
| 39 | MP0001764_abnormal_homeostasis | 1.53606381 |
| 40 | MP0004272_abnormal_basement_membrane | 1.53259175 |
| 41 | MP0003941_abnormal_skin_development | 1.52273764 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.47051114 |
| 43 | MP0005023_abnormal_wound_healing | 1.43657754 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.42588104 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.40104581 |
| 46 | MP0005451_abnormal_body_composition | 1.34363000 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.33732730 |
| 48 | MP0009764_decreased_sensitivity_to | 1.28408984 |
| 49 | MP0005165_increased_susceptibility_to | 1.25562666 |
| 50 | MP0002060_abnormal_skin_morphology | 1.24962478 |
| 51 | MP0000604_amyloidosis | 1.24455390 |
| 52 | MP0008007_abnormal_cellular_replicative | 1.21343390 |
| 53 | MP0005623_abnormal_meninges_morphology | 1.20262307 |
| 54 | MP0003690_abnormal_glial_cell | 1.20248432 |
| 55 | MP0000598_abnormal_liver_morphology | 1.19131090 |
| 56 | MP0004233_abnormal_muscle_weight | 1.18908870 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.17457173 |
| 58 | MP0000383_abnormal_hair_follicle | 1.13276391 |
| 59 | * MP0008469_abnormal_protein_level | 1.10434988 |
| 60 | MP0003786_premature_aging | 1.06482959 |
| 61 | MP0002163_abnormal_gland_morphology | 1.05801146 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 1.01324967 |
| 63 | MP0000427_abnormal_hair_cycle | 1.00087597 |
| 64 | * MP0009763_increased_sensitivity_to | 0.99845428 |
| 65 | MP0002168_other_aberrant_phenotype | 0.99552852 |
| 66 | MP0001944_abnormal_pancreas_morphology | 0.97030803 |
| 67 | MP0002332_abnormal_exercise_endurance | 0.96051889 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 0.94076680 |
| 69 | MP0001756_abnormal_urination | 0.93678639 |
| 70 | MP0004215_abnormal_myocardial_fiber | 0.93207448 |
| 71 | MP0004957_abnormal_blastocyst_morpholog | 0.92477435 |
| 72 | MP0004084_abnormal_cardiac_muscle | 0.92258536 |
| 73 | MP0001216_abnormal_epidermal_layer | 0.92163669 |
| 74 | MP0005464_abnormal_platelet_physiology | 0.91765116 |
| 75 | MP0002693_abnormal_pancreas_physiology | 0.91716860 |
| 76 | MP0000920_abnormal_myelination | 0.91489866 |
| 77 | MP0003329_amyloid_beta_deposits | 0.90883322 |
| 78 | MP0009697_abnormal_copulation | 0.90695318 |
| 79 | MP0005535_abnormal_body_temperature | 0.89065774 |
| 80 | MP0006082_CNS_inflammation | 0.87598859 |
| 81 | * MP0009642_abnormal_blood_homeostasis | 0.86986260 |
| 82 | MP0005376_homeostasis/metabolism_phenot | 0.86829064 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.86020909 |
| 84 | MP0000358_abnormal_cell_content/ | 0.84142365 |
| 85 | MP0003045_fibrosis | 0.83788476 |
| 86 | MP0004130_abnormal_muscle_cell | 0.82561745 |
| 87 | MP0003300_gastrointestinal_ulcer | 0.81845828 |
| 88 | MP0001243_abnormal_dermal_layer | 0.81542614 |
| 89 | MP0005408_hypopigmentation | 0.80281033 |
| 90 | MP0005647_abnormal_sex_gland | 0.79707596 |
| 91 | MP0002971_abnormal_brown_adipose | 0.79594516 |
| 92 | MP0001661_extended_life_span | 0.78824988 |
| 93 | * MP0009765_abnormal_xenobiotic_induced | 0.77577063 |
| 94 | MP0002078_abnormal_glucose_homeostasis | 0.77222359 |
| 95 | MP0002295_abnormal_pulmonary_circulatio | 0.77053387 |
| 96 | MP0005266_abnormal_metabolism | 0.76450035 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.76216887 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 0.74135792 |
| 99 | MP0003011_delayed_dark_adaptation | 0.74088478 |
| 100 | MP0001915_intracranial_hemorrhage | 0.73627417 |
| 101 | MP0000647_abnormal_sebaceous_gland | 0.73214675 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.73080556 |
| 103 | MP0001191_abnormal_skin_condition | 0.72369847 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.71156219 |
| 105 | MP0008004_abnormal_stomach_pH | 0.70582302 |
| 106 | MP0005670_abnormal_white_adipose | 0.70493854 |
| 107 | MP0006035_abnormal_mitochondrial_morpho | 0.70250743 |
| 108 | MP0003436_decreased_susceptibility_to | 0.69085334 |
| 109 | MP0010771_integument_phenotype | 0.68558895 |
| 110 | MP0005330_cardiomyopathy | 0.67383523 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.65924648 |
| 112 | MP0005334_abnormal_fat_pad | 0.65880863 |
| 113 | MP0005501_abnormal_skin_physiology | 0.64335169 |
| 114 | MP0005410_abnormal_fertilization | 0.62591362 |
| 115 | MP0003303_peritoneal_inflammation | 0.62552203 |
| 116 | MP0003075_altered_response_to | 0.61954283 |
| 117 | MP0002972_abnormal_cardiac_muscle | 0.59620010 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.59011243 |
| 119 | MP0004036_abnormal_muscle_relaxation | 0.58901198 |
| 120 | MP0004185_abnormal_adipocyte_glucose | 0.56174116 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.54588074 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.54085150 |
| 123 | * MP0008873_increased_physiological_sensi | 0.53532732 |
| 124 | MP0009785_altered_susceptibility_to | 0.52863328 |
| 125 | MP0003172_abnormal_lysosome_physiology | 0.49381072 |
| 126 | MP0002419_abnormal_innate_immunity | 0.48033633 |
| 127 | MP0002254_reproductive_system_inflammat | 0.46964625 |
| 128 | MP0005025_abnormal_response_to | 0.46936538 |
| 129 | MP0002876_abnormal_thyroid_physiology | 0.45532047 |
| 130 | MP0005164_abnormal_response_to | 0.45306893 |
| 131 | MP0005395_other_phenotype | 0.44127530 |
| 132 | MP0010368_abnormal_lymphatic_system | 0.43695644 |
| 133 | MP0005166_decreased_susceptibility_to | 0.43450653 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.41537156 |
| 135 | MP0000639_abnormal_adrenal_gland | 0.41498483 |
| 136 | MP0005397_hematopoietic_system_phenotyp | 0.41224483 |
| 137 | MP0001545_abnormal_hematopoietic_system | 0.41224483 |
| 138 | MP0003718_maternal_effect | 0.41160441 |
| 139 | MP0008874_decreased_physiological_sensi | 0.41145130 |
| 140 | MP0002928_abnormal_bile_duct | 0.40804841 |
| 141 | MP0002970_abnormal_white_adipose | 0.40083343 |
| 142 | MP0005448_abnormal_energy_balance | 0.40047009 |
| 143 | MP0003705_abnormal_hypodermis_morpholog | 0.39350155 |
| 144 | MP0004142_abnormal_muscle_tone | 0.38097276 |
| 145 | MP0000343_altered_response_to | 0.36262285 |
| 146 | MP0003953_abnormal_hormone_level | 0.35595936 |
| 147 | MP0005167_abnormal_blood-brain_barrier | 0.35243258 |
| 148 | MP0001853_heart_inflammation | 0.34103619 |
| 149 | MP0001533_abnormal_skeleton_physiology | 0.33354451 |
| 150 | MP0004264_abnormal_extraembryonic_tissu | 0.32556813 |
| 151 | MP0001881_abnormal_mammary_gland | 0.32073206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.52517245 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.18659721 |
| 3 | Xanthomatosis (HP:0000991) | 5.34408127 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.26366136 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.25899267 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.67973351 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.63224847 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 4.57160955 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12937201 |
| 10 | Hyperkalemia (HP:0002153) | 4.12237537 |
| 11 | Hyperammonemia (HP:0001987) | 3.97557152 |
| 12 | Complement deficiency (HP:0004431) | 3.91772587 |
| 13 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.86991658 |
| 14 | Ketosis (HP:0001946) | 3.85905939 |
| 15 | Nuclear cataract (HP:0100018) | 3.75959843 |
| 16 | Fat malabsorption (HP:0002630) | 3.72153283 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.70833508 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70394910 |
| 19 | Increased circulating renin level (HP:0000848) | 3.68248506 |
| 20 | Joint hemorrhage (HP:0005261) | 3.64979998 |
| 21 | Hyperbilirubinemia (HP:0002904) | 3.64016610 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.61903936 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.61903936 |
| 24 | Epidermoid cyst (HP:0200040) | 3.60693027 |
| 25 | Hyperglycinuria (HP:0003108) | 3.59204690 |
| 26 | Hyperglycinemia (HP:0002154) | 3.58115554 |
| 27 | Absent/shortened dynein arms (HP:0200106) | 3.51785890 |
| 28 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.51785890 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.48124534 |
| 30 | Acanthocytosis (HP:0001927) | 3.44772716 |
| 31 | Hypolipoproteinemia (HP:0010981) | 3.43870613 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.42747537 |
| 33 | Hyperactive renin-angiotensin system (HP:0000841) | 3.37224156 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.35369364 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.29624870 |
| 36 | Poikilocytosis (HP:0004447) | 3.23727232 |
| 37 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.22141037 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.13473241 |
| 39 | Decreased circulating renin level (HP:0003351) | 3.11781816 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 3.08984221 |
| 41 | Ketoacidosis (HP:0001993) | 3.04500753 |
| 42 | Gout (HP:0001997) | 3.00464591 |
| 43 | Steatorrhea (HP:0002570) | 3.00385856 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98797987 |
| 45 | Tetraparesis (HP:0002273) | 2.98484458 |
| 46 | Abnormality of complement system (HP:0005339) | 2.97672053 |
| 47 | Hypercholesterolemia (HP:0003124) | 2.95907999 |
| 48 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.94008755 |
| 49 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.94008755 |
| 50 | Hypoalphalipoproteinemia (HP:0003233) | 2.93880531 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.93600962 |
| 52 | Toxemia of pregnancy (HP:0100603) | 2.91315655 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.89525915 |
| 54 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.88062389 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.86718848 |
| 56 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.83762969 |
| 57 | Rhinitis (HP:0012384) | 2.81272073 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.78425519 |
| 59 | Abnormal ciliary motility (HP:0012262) | 2.78262810 |
| 60 | Abnormality of serum amino acid levels (HP:0003112) | 2.76980739 |
| 61 | Delayed CNS myelination (HP:0002188) | 2.75801446 |
| 62 | Metabolic acidosis (HP:0001942) | 2.75060826 |
| 63 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.74937272 |
| 64 | Abnormal gallbladder morphology (HP:0012437) | 2.73427886 |
| 65 | Cholelithiasis (HP:0001081) | 2.67784043 |
| 66 | Proximal tubulopathy (HP:0000114) | 2.67302555 |
| 67 | Hyponatremia (HP:0002902) | 2.66898752 |
| 68 | Hepatocellular carcinoma (HP:0001402) | 2.64806699 |
| 69 | Lethargy (HP:0001254) | 2.63913512 |
| 70 | Dicarboxylic aciduria (HP:0003215) | 2.63774167 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.63774167 |
| 72 | Vascular calcification (HP:0004934) | 2.59715699 |
| 73 | Reticulocytosis (HP:0001923) | 2.56778310 |
| 74 | Myocardial infarction (HP:0001658) | 2.54991831 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.53144178 |
| 76 | Cerebral edema (HP:0002181) | 2.52813082 |
| 77 | Mitral stenosis (HP:0001718) | 2.51875036 |
| 78 | Cholecystitis (HP:0001082) | 2.50798342 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.50798342 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49490874 |
| 81 | Nausea (HP:0002018) | 2.49141612 |
| 82 | Increased serum ferritin (HP:0003281) | 2.48247458 |
| 83 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.48142477 |
| 84 | Alkalosis (HP:0001948) | 2.44507141 |
| 85 | Hypokinesia (HP:0002375) | 2.42919131 |
| 86 | Vomiting (HP:0002013) | 2.36442452 |
| 87 | Premature rupture of membranes (HP:0001788) | 2.34980211 |
| 88 | Glycosuria (HP:0003076) | 2.32972470 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.32972470 |
| 90 | Rickets (HP:0002748) | 2.32906945 |
| 91 | Irritability (HP:0000737) | 2.32872770 |
| 92 | Hypoglycemic seizures (HP:0002173) | 2.30873835 |
| 93 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.29422793 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.28783048 |
| 95 | Back pain (HP:0003418) | 2.28342880 |
| 96 | Spastic diplegia (HP:0001264) | 2.26453511 |
| 97 | Pancreatitis (HP:0001733) | 2.25252217 |
| 98 | Hydroxyprolinuria (HP:0003080) | 2.22734669 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 2.22734669 |
| 100 | Severe visual impairment (HP:0001141) | 2.22532816 |
| 101 | Increased purine levels (HP:0004368) | 2.21116726 |
| 102 | Hyperuricemia (HP:0002149) | 2.21116726 |
| 103 | Cardiovascular calcification (HP:0011915) | 2.19712092 |
| 104 | Abnormality of the gallbladder (HP:0005264) | 2.18907245 |
| 105 | Axonal loss (HP:0003447) | 2.18733386 |
| 106 | Biliary tract neoplasm (HP:0100574) | 2.18512677 |
| 107 | Congenital cataract (HP:0000519) | 2.16766346 |
| 108 | Ileus (HP:0002595) | 2.16763071 |
| 109 | Osteolytic defects of the hand bones (HP:0009699) | 2.15881127 |
| 110 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.15881127 |
| 111 | Rectal prolapse (HP:0002035) | 2.15076739 |
| 112 | Menorrhagia (HP:0000132) | 2.15076010 |
| 113 | Brushfield spots (HP:0001088) | 2.14732228 |
| 114 | Systemic lupus erythematosus (HP:0002725) | 2.14593201 |
| 115 | Skin nodule (HP:0200036) | 2.14179955 |
| 116 | Paralysis (HP:0003470) | 2.13859639 |
| 117 | Abnormal biliary tract morphology (HP:0012440) | 2.11485789 |
| 118 | Short nail (HP:0001799) | 2.11260681 |
| 119 | Opisthotonus (HP:0002179) | 2.08957879 |
| 120 | Hyperthyroidism (HP:0000836) | 2.06706345 |
| 121 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.05641445 |
| 122 | Progressive hearing impairment (HP:0001730) | 2.05252775 |
| 123 | Metaphyseal dysplasia (HP:0100255) | 2.03831812 |
| 124 | Palpitations (HP:0001962) | 2.03148679 |
| 125 | Spontaneous abortion (HP:0005268) | 2.02785200 |
| 126 | Vacuolated lymphocytes (HP:0001922) | 2.02565926 |
| 127 | Amyloidosis (HP:0011034) | 2.02270364 |
| 128 | Hyperglycemia (HP:0003074) | 2.01615489 |
| 129 | Spastic paraparesis (HP:0002313) | 2.01420803 |
| 130 | Abnormality of sodium homeostasis (HP:0010931) | 1.99760671 |
| 131 | Increased mean platelet volume (HP:0011877) | 1.99345734 |
| 132 | Hyperphosphatemia (HP:0002905) | 1.98522085 |
| 133 | Malnutrition (HP:0004395) | 1.98342046 |
| 134 | Abnormal hemoglobin (HP:0011902) | 1.97976933 |
| 135 | Gingival bleeding (HP:0000225) | 1.97703493 |
| 136 | Abnormality of chloride homeostasis (HP:0011422) | 1.97561671 |
| 137 | Unilateral renal agenesis (HP:0000122) | 1.94808770 |
| 138 | Azoospermia (HP:0000027) | 1.93409945 |
| 139 | Sex reversal (HP:0012245) | 1.93150703 |
| 140 | Abnormal sex determination (HP:0012244) | 1.93150703 |
| 141 | Hematochezia (HP:0002573) | 1.91984709 |
| 142 | Polycythemia (HP:0001901) | 1.91044434 |
| 143 | Confusion (HP:0001289) | 1.90755471 |
| 144 | Hypokalemic alkalosis (HP:0001949) | 1.90715347 |
| 145 | Hyperphosphaturia (HP:0003109) | 1.90352105 |
| 146 | Zonular cataract (HP:0010920) | 1.90217820 |
| 147 | Late onset (HP:0003584) | 1.89374892 |
| 148 | Central scotoma (HP:0000603) | 1.88425806 |
| 149 | Abnormality of vitamin metabolism (HP:0100508) | 1.87078300 |
| 150 | Upper limb muscle weakness (HP:0003484) | 1.85605734 |
| 151 | Fair hair (HP:0002286) | 1.84327159 |
| 152 | Abnormality of potassium homeostasis (HP:0011042) | 1.82856860 |
| 153 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.81646646 |
| 154 | Abnormality of alanine metabolism (HP:0010916) | 1.81646646 |
| 155 | Hyperalaninemia (HP:0003348) | 1.81646646 |
| 156 | Follicular hyperkeratosis (HP:0007502) | 1.80864234 |
| 157 | Male infertility (HP:0003251) | 1.78082598 |
| 158 | Hypoplasia of the uterus (HP:0000013) | 1.77222097 |
| 159 | Symptomatic seizures (HP:0011145) | 1.71713724 |
| 160 | Renal cortical cysts (HP:0000803) | 1.71214001 |
| 161 | Neoplasm of the rectum (HP:0100743) | 1.71126213 |
| 162 | Abnormality of macular pigmentation (HP:0008002) | 1.67233682 |
| 163 | Progressive muscle weakness (HP:0003323) | 1.66045365 |
| 164 | Bronchiectasis (HP:0002110) | 1.65949699 |
| 165 | Chronic bronchitis (HP:0004469) | 1.65246472 |
| 166 | Hyperaldosteronism (HP:0000859) | 1.65031022 |
| 167 | Abnormality of renin-angiotensin system (HP:0000847) | 1.64072318 |
| 168 | Onycholysis (HP:0001806) | 1.62459883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.40460675 |
| 2 | PBK | 3.75495338 |
| 3 | OXSR1 | 3.29122281 |
| 4 | TAOK3 | 3.19695060 |
| 5 | WNK4 | 3.08443005 |
| 6 | STK39 | 3.01808660 |
| 7 | NME2 | 2.90120100 |
| 8 | ERN1 | 2.89937015 |
| 9 | ERBB4 | 2.80501561 |
| 10 | EIF2AK1 | 2.69029686 |
| 11 | BRSK2 | 2.27777916 |
| 12 | ABL2 | 2.23626860 |
| 13 | EPHB1 | 2.22314104 |
| 14 | EPHA2 | 2.05989456 |
| 15 | WNK3 | 2.01842686 |
| 16 | FGFR4 | 1.97296570 |
| 17 | MST1R | 1.95010595 |
| 18 | IRAK3 | 1.94147648 |
| 19 | NEK1 | 1.88911142 |
| 20 | SIK1 | 1.87320594 |
| 21 | MAP3K11 | 1.78572766 |
| 22 | TBK1 | 1.72293972 |
| 23 | LMTK2 | 1.66969029 |
| 24 | MAP2K6 | 1.64299155 |
| 25 | MAP3K12 | 1.60046950 |
| 26 | BUB1 | 1.53926790 |
| 27 | MET | 1.53319442 |
| 28 | PINK1 | 1.51157995 |
| 29 | MAPK15 | 1.48669259 |
| 30 | TTK | 1.47055978 |
| 31 | PIM2 | 1.44990095 |
| 32 | MAPK11 | 1.40360594 |
| 33 | INSRR | 1.35521883 |
| 34 | JAK2 | 1.30412560 |
| 35 | TAOK2 | 1.25378531 |
| 36 | ACVR1B | 1.24091742 |
| 37 | SCYL2 | 1.22513416 |
| 38 | CLK1 | 1.22302576 |
| 39 | MAPKAPK5 | 1.16501929 |
| 40 | MAP2K2 | 1.11427597 |
| 41 | CSK | 1.11282768 |
| 42 | TYK2 | 1.10627245 |
| 43 | NEK9 | 1.09693811 |
| 44 | MST4 | 1.08288896 |
| 45 | TESK2 | 1.08088970 |
| 46 | MYLK | 1.07890350 |
| 47 | CDK8 | 1.06949665 |
| 48 | MAPKAPK3 | 1.06612254 |
| 49 | ADRBK2 | 1.04786637 |
| 50 | ERBB3 | 1.03223158 |
| 51 | STK16 | 1.03122239 |
| 52 | TSSK6 | 1.01659300 |
| 53 | BMX | 1.01338263 |
| 54 | PIK3CG | 0.99115497 |
| 55 | LATS2 | 0.98964507 |
| 56 | PTK2B | 0.96290425 |
| 57 | PHKG1 | 0.94815649 |
| 58 | PHKG2 | 0.94815649 |
| 59 | LATS1 | 0.93702704 |
| 60 | PAK4 | 0.92678355 |
| 61 | KDR | 0.91507918 |
| 62 | ZAK | 0.90002401 |
| 63 | IRAK1 | 0.89400261 |
| 64 | PDK2 | 0.89286418 |
| 65 | CDK6 | 0.87685904 |
| 66 | WEE1 | 0.87509993 |
| 67 | FLT3 | 0.87204457 |
| 68 | MAP3K2 | 0.87124812 |
| 69 | DYRK1B | 0.87081054 |
| 70 | FER | 0.84966298 |
| 71 | PASK | 0.84642561 |
| 72 | PRKCI | 0.84507823 |
| 73 | CDK19 | 0.83640654 |
| 74 | GRK1 | 0.83334025 |
| 75 | MAP3K14 | 0.82149314 |
| 76 | BMPR2 | 0.80573683 |
| 77 | TRIB3 | 0.79469419 |
| 78 | PLK3 | 0.79234895 |
| 79 | KSR2 | 0.77192281 |
| 80 | PLK2 | 0.76374020 |
| 81 | PTK6 | 0.75629401 |
| 82 | MELK | 0.75000173 |
| 83 | MAP2K4 | 0.74855757 |
| 84 | IRAK4 | 0.74347660 |
| 85 | PRKAA2 | 0.73936527 |
| 86 | MAP3K1 | 0.72000088 |
| 87 | CAMKK2 | 0.71623476 |
| 88 | MAPK4 | 0.71270133 |
| 89 | STK4 | 0.71211142 |
| 90 | GSK3A | 0.70788763 |
| 91 | CSNK1G3 | 0.70501188 |
| 92 | PDPK1 | 0.69478014 |
| 93 | TEC | 0.68411449 |
| 94 | BLK | 0.67703057 |
| 95 | PLK1 | 0.66126882 |
| 96 | ERBB2 | 0.65973864 |
| 97 | CSNK1G1 | 0.65884695 |
| 98 | IKBKE | 0.65864698 |
| 99 | PNCK | 0.64496090 |
| 100 | IRAK2 | 0.64160005 |
| 101 | MAP3K13 | 0.63673155 |
| 102 | CAMK2G | 0.63630568 |
| 103 | STK24 | 0.62650638 |
| 104 | TTN | 0.61493695 |
| 105 | TLK1 | 0.61118207 |
| 106 | MATK | 0.61102546 |
| 107 | PIM1 | 0.59877745 |
| 108 | MAP3K8 | 0.59232701 |
| 109 | STK38L | 0.57121917 |
| 110 | MAP2K1 | 0.55889725 |
| 111 | GRK6 | 0.54388723 |
| 112 | LRRK2 | 0.52595185 |
| 113 | PRKACG | 0.52007548 |
| 114 | MAP3K9 | 0.51151390 |
| 115 | EGFR | 0.51066906 |
| 116 | MAP2K3 | 0.50748158 |
| 117 | PRKCE | 0.50487871 |
| 118 | STK10 | 0.50115411 |
| 119 | EIF2AK3 | 0.49285905 |
| 120 | MAP3K3 | 0.49041664 |
| 121 | IKBKB | 0.48949127 |
| 122 | ABL1 | 0.48935921 |
| 123 | NTRK1 | 0.48092907 |
| 124 | STK3 | 0.47376109 |
| 125 | ICK | 0.46950160 |
| 126 | CSNK1G2 | 0.46499680 |
| 127 | FGR | 0.45655923 |
| 128 | BRSK1 | 0.44865443 |
| 129 | TIE1 | 0.44665105 |
| 130 | CHEK2 | 0.44347007 |
| 131 | PRKG2 | 0.44058004 |
| 132 | PTK2 | 0.43171405 |
| 133 | EIF2AK2 | 0.42950718 |
| 134 | LYN | 0.42556278 |
| 135 | KIT | 0.42181831 |
| 136 | ARAF | 0.40295451 |
| 137 | PRKCD | 0.40244135 |
| 138 | AKT2 | 0.39896081 |
| 139 | PRKCQ | 0.39849354 |
| 140 | STK38 | 0.39534806 |
| 141 | FRK | 0.39479489 |
| 142 | PRKCZ | 0.38912549 |
| 143 | WNK1 | 0.38044728 |
| 144 | ADRBK1 | 0.35370066 |
| 145 | CSNK1A1L | 0.34899609 |
| 146 | CAMK2D | 0.34891947 |
| 147 | CHEK1 | 0.34661038 |
| 148 | LIMK1 | 0.33872596 |
| 149 | KSR1 | 0.33622396 |
| 150 | BRAF | 0.33553394 |
| 151 | DYRK3 | 0.33279341 |
| 152 | PKN2 | 0.33102848 |
| 153 | TRPM7 | 0.32486057 |
| 154 | DAPK2 | 0.31710946 |
| 155 | GRK7 | 0.31136535 |
| 156 | BMPR1B | 0.30303022 |
| 157 | NEK2 | 0.29435589 |
| 158 | CASK | 0.29411316 |
| 159 | HIPK2 | 0.29392082 |
| 160 | RPS6KB2 | 0.28711352 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.85756731 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.46123354 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24565706 |
| 4 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.68513179 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61652388 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.57847053 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.49768598 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.48399759 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.46069431 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45651466 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.39355339 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31506542 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.28808924 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.22601886 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.21755893 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08677660 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07815853 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.98589064 |
| 19 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.97453735 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94998556 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91339806 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.83771720 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83499382 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80783358 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.79497708 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.76222293 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75580841 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69081634 |
| 29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.63339900 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.62630879 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62614660 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.61087424 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56477654 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54799949 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52617814 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49011100 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46709596 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.45259340 |
| 39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.43890598 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43255420 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43053130 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.42135498 |
| 43 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.39321676 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.29005372 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.25069386 |
| 46 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.20895612 |
| 47 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.20347414 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.19508508 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18077044 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.17579557 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16330439 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16280594 |
| 53 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.15315610 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14868980 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.13404140 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13066436 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.12958946 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12021670 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08699216 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08201928 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07143977 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06537979 |
| 63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05766167 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04427093 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.94614468 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.87834593 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84377691 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75412096 |
| 69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.74207834 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73969622 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73114262 |
| 72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72541549 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71313527 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67333777 |
| 75 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.60438323 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56299392 |
| 77 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54154959 |
| 78 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52495084 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.52075299 |
| 80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.51650281 |
| 81 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.51534285 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43851915 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42673281 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41626291 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40156665 |
| 86 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39513479 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.38254912 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38168113 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36668260 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34912422 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34582738 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33902604 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33372876 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.28512015 |
| 95 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.28465200 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.27683661 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25941227 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.25890639 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.25617380 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25436534 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.25394743 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.24119006 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22826313 |
| 104 | Protein export_Homo sapiens_hsa03060 | 0.21729408 |
| 105 | Legionellosis_Homo sapiens_hsa05134 | 0.20235090 |
| 106 | Parkinsons disease_Homo sapiens_hsa05012 | 0.16487673 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15493545 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.14650368 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14525884 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12017110 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.07689253 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.07166726 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05387959 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04321338 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.03968460 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.03654254 |
| 117 | Alzheimers disease_Homo sapiens_hsa05010 | 0.02279464 |
| 118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.01009221 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00694719 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1262616 |
| 121 | Huntingtons disease_Homo sapiens_hsa05016 | -0.1210004 |
| 122 | Pertussis_Homo sapiens_hsa05133 | -0.0970086 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | -0.0861648 |
| 124 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0639140 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0468676 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | -0.0239712 |
| 127 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0174832 |

